Compound Pharmacy Group Cheers Lilly Loss In Compound GLP-1 Lawsuit

By Jessica Karins / April 16, 2024 at 4:59 PM
The trade organization for compounding pharmacies is praising a Florida federal judge’s decision to toss out Eli Lilly’s lawsuit against an online pharmacy that offers compounded versions of its popular diabetes and weight loss drug tirzepatide (Mounjaro), saying Lilly, and fellow GLP-1 manufacturer Novo Nordisk, are using frivolous litigation to discourage compounding. The court said FDA has jurisdiction over compounding, coming as the agency allows compounding of drugs in shortage, which include weight-loss drugs, but has also warned consumers that...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.